Skip to main content
Log in

Ex-drinking may be a surrogate for unmeasured risk factors for upper gastrointestinal bleeding: reappraisal and an additional survey of subjects from a case–control study in Japan

  • GASTRO-INTESTINAL DISEASES
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

In our recent case–control study on the association between non-steroidal anti-inflammatory drugs (NSAIDs) and upper gastrointestinal bleeding (UGIB), the risk of UGIB was higher in non-drinkers than in heavy-drinkers. To explore this unexpected finding, we re-analyzed the data to test whether non-drinking represented risk factors for UGIB and also conducted an additional survey to find any disagreement with the original study that might suggest information bias. In the re-analysis, we estimated odds ratios (ORs) of UGIB by classifying 183 non-drinkers in the original study into 39 ex- and 144 never-drinkers. We also measured the prevalence of potential risk factors of UGIB in controls. In the new survey, we sent a self-administered questionnaire on previous alcohol consumption. In the re-analysis, the OR for ex-drinking (5.4) was higher and the OR for never-drinking (2.6) was lower than the OR for non- (ex- plus never-) drinking (3.2) in the original study. Ex-drinkers had higher prevalence of H. pylori infection, history of previous ulcer and use of GI drugs than other types of drinkers. The answers on their previous alcohol consumption were consistent between the original and new surveys both in cases (κ = 0.74) and controls (κ = 0.73). Ex-drinking may represent unmeasured risk factors for UGIB such as undiagnosed ulcer. In an observational study of UGIB, ex-drinking may be distinguished from never-drinking as a potential surrogate for UGIB risk. When prescribing an NSAID to an ex-drinker in clinical practice, one may make sure to explore whether an ex-drinker has a history of ulcer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

GI:

Gastrointestinal

NSAIDs:

Non-steroidal anti-inflammatory drugs

OR:

Odds ratio

UGIB:

Upper gastrointestinal bleeding

References

  1. Kelly JP, Kaufman DW, Koff RS, Laszlo A, Wiholm BE, Shapiro S. Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol. 1995;90:1058–64.

    PubMed  CAS  Google Scholar 

  2. Andersen IB, Jorgensen T, Bonnevie O, Gronbaek M, Sorensen TIA. Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: a population-based cohort study. Epidemiology. 2000;11:434–9. doi:10.1097/00001648-200007000-00012.

    Article  PubMed  CAS  Google Scholar 

  3. Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94:3189–96. doi:10.1111/j.1572-0241.1999.01517.x.

    Article  PubMed  CAS  Google Scholar 

  4. Vidal X, Ibanez L, Vendrell L, Conforti A, Laporte JR. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants. Drug Saf. 2008;31:159–68.

    Article  PubMed  CAS  Google Scholar 

  5. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding : confusion or confounding? Am J Med. 2006;119:719–27. doi:10.1016/j.amjmed.2005.11.006.

    Article  PubMed  CAS  Google Scholar 

  6. de Abajo FJ, Rodriguez LAG, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case–control study. BMJ. 1999;319:1106–9.

    PubMed  Google Scholar 

  7. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163:59–64. doi:10.1001/archinte.163.1.59.

    Article  PubMed  CAS  Google Scholar 

  8. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;323:1–6. doi:10.1136/bmj.323.7314.655.

    Article  Google Scholar 

  9. Dunn NR, Pearce GL, Shakir SAW. Association between SSRIs and upper gastrointestinal bleeding: SSRIs are no more likely than other drugs to cause such bleeding. BMJ. 2000;320:1405–6. doi:10.1136/bmj.320.7246.1405.

    Article  PubMed  CAS  Google Scholar 

  10. Gulmez SE, Lassen AT, Aalykke C, et al. Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case–control study. Br J Clin Pharmacol. 2008;66:294–9. doi:10.1111/j.1365-2125.2008.03205.x.

    Article  PubMed  CAS  Google Scholar 

  11. Verhamme KMC, Mosis G, Dieleman JP, Stricker BHC, Sturkenboom MCJM. Spironolactone and risk of upper gastrointestinal events: population based case–control study. BMJ. 2006;333:330–3. doi:10.1136/bmj.38883.479549.2F.

    Article  PubMed  Google Scholar 

  12. Nielsen GL, Sorensen HT, Mellemkjoer L, et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med. 2001;111:541–5. doi:10.1016/S0002-9343(01)00941-X.

    Article  PubMed  CAS  Google Scholar 

  13. Marshall JK, Rainsford KD, James C, Hunt RH. A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract. Aliment Pharmacol Ther. 2000;14:1451–7. doi:10.1046/j.1365-2036.2000.00864.x.

    Article  PubMed  CAS  Google Scholar 

  14. Graham DY, Malaty HM. Alendronate gastric ulcers. Aliment Pharmacol Ther. 1999;13:515–9. doi:10.1046/j.1365-2036.1999.00488.x.

    Article  PubMed  CAS  Google Scholar 

  15. Bauer DC, Black D, Ensrud K, et al. Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med. 2000;160:517–25. doi:10.1001/archinte.160.4.517.

    Article  PubMed  CAS  Google Scholar 

  16. Sakamoto C, Sugano K, Ota S, et al. Case–control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol. 2006;62:765–72. doi:10.1007/s00228-006-0171-6.

    Article  PubMed  CAS  Google Scholar 

  17. Cohen J A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;XX:37–46. doi:10.1177/001316446002000104.

  18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74. doi:10.2307/2529310.

    Article  PubMed  CAS  Google Scholar 

  19. Hartge P, Cahill J. Field methods in epidemiology. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 492–510.

    Google Scholar 

  20. Midanik L. The validity of self-reported alcohol consumption and alcohol problems: a literature review. Br J Addict. 1982;77:357–82. doi:10.1111/j.1360-0443.1982.tb02469.x.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was re-analysis of the previous study supported by Pfizer and Astellas. Our study was approved by the Ethical Board of the Public Health Research Foundation, Shinjuku, Tokyo.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyoshi Kubota.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, H., Kamijima, Y., Sato, T. et al. Ex-drinking may be a surrogate for unmeasured risk factors for upper gastrointestinal bleeding: reappraisal and an additional survey of subjects from a case–control study in Japan. Eur J Epidemiol 24, 143–147 (2009). https://doi.org/10.1007/s10654-009-9319-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-009-9319-x

Keywords

Navigation